Muscle Delivery of Mitochondria-Targeted Drugs for the Treatment of Sarcopenia: Rationale and Perspectives
An impairment in mitochondrial homeostasis plays a crucial role in the process of aging and contributes to the incidence of age-related diseases, including sarcopenia, which is defined as an age-dependent loss of muscle mass and strength. Mitochondrial dysfunction exerts a negative impact on several...
Main Authors: | Francesco Bellanti, Aurelio Lo Buglio, Gianluigi Vendemiale |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/12/2588 |
Similar Items
-
Mitochondrial Impairment in Sarcopenia
by: Francesco Bellanti, et al.
Published: (2021-01-01) -
Sarcopenia Is Associated with Changes in Circulating Markers of Antioxidant/Oxidant Balance and Innate Immune Response
by: Francesco Bellanti, et al.
Published: (2023-11-01) -
Hepatic Mitochondria-Gut Microbiota Interactions in Metabolism-Associated Fatty Liver Disease
by: Francesco Bellanti, et al.
Published: (2023-02-01) -
Advances in exercise to alleviate sarcopenia in older adults by improving mitochondrial dysfunction
by: Yang Zhu, et al.
Published: (2023-07-01) -
Redox Homeostasis and Immune Alterations in Coronavirus Disease-19
by: Francesco Bellanti, et al.
Published: (2022-01-01)